| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-07 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.12 | 2e-05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.12 | 5e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 6e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 8e-05 |